Game-changing uPAR-targeting dye for guiding surgical treatment of cancer

Rezultaty

Publication of initial clinical result
Publication of clinical trial metrology

Publikacje

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts

Autorzy: Sorel Kurbegovic, Karina Juhl, Kasper Kildegaard Sørensen, Julie Leth, Gro Linno Willemoe, Anders Christensen, Yvonne Adams, Anja Ramstedt Jensen, Christian von Buchwald, Jane Skjøth-Rasmussen, Michael Ploug, Knud J. Jensen, Andreas Kjaer
Opublikowane w: Theranostics, Numer 11/15, 2021, Strona(/y) 7159-7174, ISSN 1838-7640
Wydawca: Ivyspring International Publisher
DOI: 10.7150/thno.49787

Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial

Autorzy: Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso, Andreas Kjaer
Opublikowane w: Journal of Nuclear Medicine, Numer 62/3, 2021, Strona(/y) 354-359, ISSN 0161-5505
Wydawca: Kexue Chubaneshe/Science Press
DOI: 10.2967/jnumed.120.248120

Prawa własności intelektualnej

UPAR TARGETING PEPTIDE FOR USE IN PEROPERATIVE OPTICAL IMAGING OF INVASIVE CANCER

Numer wniosku/publikacji: 15 842107
Data: 2015-09-03
Wnioskodawca/wnioskodawcy: FLUOGUIDE AS

A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE PHARMACOKINETIC PROFILE

Numer wniosku/publikacji: 20 20069991
Data: 2020-07-15
Wnioskodawca/wnioskodawcy: FLUOGUIDE AS

uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY

Numer wniosku/publikacji: 20 20087653
Data: 2020-12-22
Wnioskodawca/wnioskodawcy: FLUOGUIDE AS

A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE

Numer wniosku/publikacji: 20 20070014
Data: 2020-07-15
Wnioskodawca/wnioskodawcy: FLUOGUIDE AS